Y-27632 dihydrochloride
To Order Contact us: stephen@expresspharmapulse.com
Y-27632 dihydrochloride |
|||
A3008-200 | ApexBio | 200 mg | EUR 1284 |
Description: Y-27632 dihydrochloride is a small-molecule inhibitor of Rho-associated protein kinase p160ROCK with the IC50 of 140 nM. Y-27632 suppresses the kinase activity of both ROCK-1 and ROCK-2 in vitro, and this compound inhibits the kinases by binding to the catalytic site of ROCK-1 and ROCK-2. |
Y-27632 dihydrochloride |
|||
A3008-5.1 | ApexBio | 10 mM (in 1mL DMSO) | EUR 177.6 |
Description: Y-27632 dihydrochloride is a small-molecule inhibitor of Rho-associated protein kinase p160ROCK with the IC50 of 140 nM. Y-27632 suppresses the kinase activity of both ROCK-1 and ROCK-2 in vitro, and this compound inhibits the kinases by binding to the catalytic site of ROCK-1 and ROCK-2. |
Y-27632 dihydrochloride |
|||
A3008-50 | ApexBio | 50 mg | EUR 505.2 |
Description: Y-27632 dihydrochloride is a small-molecule inhibitor of Rho-associated protein kinase p160ROCK with the IC50 of 140 nM. Y-27632 suppresses the kinase activity of both ROCK-1 and ROCK-2 in vitro, and this compound inhibits the kinases by binding to the catalytic site of ROCK-1 and ROCK-2. |
Y-27632 dihydrochloride |
|||
GK8578-1MG | Glentham Life Sciences | 1 mg | EUR 170.4 |
Y-27632 dihydrochloride |
|||
GK8578-25MG | Glentham Life Sciences | 25 mg | EUR 945.6 |
Y-27632 dihydrochloride |
|||
GK8578-5MG | Glentham Life Sciences | 5 mg | EUR 399.6 |
Y-27632 (dihydrochloride) |
|||
HY-10583 | MedChemExpress | 50mg | EUR 349.2 |
Y-27632 |
|||
E1KS1049 | EnoGene | 2 mg | EUR 390 |
Y 27632 |
|||
20-abx076548 | Abbexa |
|
|
Y-27632 |
|||
B1293-10 | ApexBio | 10 mg | EUR 170.4 |
Description: Y-27632 is a specific inhibitor of Rho-associated kinases(ROCK) family with Ki values of 0.22?M and 0.30?M for ROCK1 and ROCK2, respectively.Y-27632 has shown selectivity of inhibition by comparing their Ki values for other Rho effector kinases, citron kinase and PKN, as well as PKC?. |
Y-27632 |
|||
B1293-200 | ApexBio | 200 mg | EUR 1284 |
Description: Y-27632 is a specific inhibitor of Rho-associated kinases(ROCK) family with Ki values of 0.22?M and 0.30?M for ROCK1 and ROCK2, respectively.Y-27632 has shown selectivity of inhibition by comparing their Ki values for other Rho effector kinases, citron kinase and PKN, as well as PKC?. |
Y-27632 |
|||
B1293-5.1 | ApexBio | 10 mM (in 1mL DMSO) | EUR 129.6 |
Description: Y-27632 is a specific inhibitor of Rho-associated kinases(ROCK) family with Ki values of 0.22?M and 0.30?M for ROCK1 and ROCK2, respectively.Y-27632 has shown selectivity of inhibition by comparing their Ki values for other Rho effector kinases, citron kinase and PKN, as well as PKC?. |
Y-27632 |
|||
B1293-50 | ApexBio | 50 mg | EUR 505.2 |
Description: Y-27632 is a specific inhibitor of Rho-associated kinases(ROCK) family with Ki values of 0.22?M and 0.30?M for ROCK1 and ROCK2, respectively.Y-27632 has shown selectivity of inhibition by comparing their Ki values for other Rho effector kinases, citron kinase and PKN, as well as PKC?. |
Y-27632 |
|||
HY-10071 | MedChemExpress | 100mg | EUR 1480.8 |
EZSolution? Y-27632 |
|||
1784-5 | Biovision | EUR 535.2 |
EZSolution? Y-27632, Sterile-Filtered |
|||
1994-1 | Biovision | EUR 430.8 |
Y 27632 (ROCK kinase inhibitor) |
|||
SIH-486-1MG | Stressmarq | 1 mg | EUR 178.8 |
Description: The substance Y 27632 is a rock kinase inhibitor. It is synthetically produced and has a purity of ?98%. The pure substance is white to pale yellow powder which is soluble in DMSO (25 mg/ml), methanol (25 mg/ml), acetonitrile (<1 mg/ml), dioxan (<1 mg/ml), water (very soluble. |
Y 27632 (ROCK kinase inhibitor) |
|||
SIH-486-5MG | Stressmarq | 5 mg | EUR 393.6 |
Description: The substance Y 27632 is a rock kinase inhibitor. It is synthetically produced and has a purity of ?98%. The pure substance is white to pale yellow powder which is soluble in DMSO (25 mg/ml), methanol (25 mg/ml), acetonitrile (<1 mg/ml), dioxan (<1 mg/ml), water (very soluble. |
Y-39983 dihydrochloride |
|||
B1176-10 | ApexBio | 10 mg | EUR 494.4 |
Description: Y-39983 dihydrochloride is a novel and selective inhibitor of ROCK family with IC50 value of 3.6nM for ROCK [1]. |
Y-39983 dihydrochloride |
|||
B1176-100 | ApexBio | 100 mg | EUR 2881.2 |
Description: Y-39983 dihydrochloride is a novel and selective inhibitor of ROCK family with IC50 value of 3.6nM for ROCK [1]. |
Y-39983 dihydrochloride |
|||
B1176-5 | ApexBio | 5 mg | EUR 320.4 |
Description: Y-39983 dihydrochloride is a novel and selective inhibitor of ROCK family with IC50 value of 3.6nM for ROCK [1]. |
Y-39983 dihydrochloride |
|||
B1176-50 | ApexBio | 50 mg | EUR 1796.4 |
Description: Y-39983 dihydrochloride is a novel and selective inhibitor of ROCK family with IC50 value of 3.6nM for ROCK [1]. |
Y-33075 (dihydrochloride) |
|||
HY-10069 | MedChemExpress | 5mg | EUR 258 |
SNRPF Polyclonal Antibody |
|||
27632-100ul | SAB | 100ul | EUR 302.4 |
SNRPF Polyclonal Antibody |
|||
27632-50ul | SAB | 50ul | EUR 224.4 |
Cefotiam Dihydrochloride |
|||
C095-100MG | TOKU-E | 100 mg | EUR 278.4 |
Cefotiam Dihydrochloride |
|||
C095-50MG | TOKU-E | 50 mg | EUR 172.8 |
Chlorhexidine Dihydrochloride |
|||
C157-25G | TOKU-E | 25 g | EUR 222 |
Chlorhexidine Dihydrochloride |
|||
C157-5G | TOKU-E | 5 g | EUR 86.4 |
Retigabine dihydrochloride |
|||
A3758-10 | ApexBio | 10 mg | EUR 164.4 |
Description: IC50: N/ARetigabine is a first-in-class K+ channel (KCNQ) opener. |
Retigabine dihydrochloride |
|||
A3758-100 | ApexBio | 100 mg | EUR 522 |
Description: IC50: N/ARetigabine is a first-in-class K+ channel (KCNQ) opener. |
Retigabine dihydrochloride |
|||
A3758-5 | ApexBio | 5 mg | EUR 126 |
Description: IC50: N/ARetigabine is a first-in-class K+ channel (KCNQ) opener. |
Retigabine dihydrochloride |
|||
A3758-5.1 | ApexBio | 10 mM (in 1mL DMSO) | EUR 170.4 |
Description: IC50: N/ARetigabine is a first-in-class K+ channel (KCNQ) opener. |
Retigabine dihydrochloride |
|||
A3758-50 | ApexBio | 50 mg | EUR 325.2 |
Description: IC50: N/ARetigabine is a first-in-class K+ channel (KCNQ) opener. |
Veliparib dihydrochloride |
|||
A3958-10 | ApexBio | 10 mg | EUR 177.6 |
Description: Veliparib dihydrochloride is a potent inhibitor of PARP-1 and PARP-2 with K (i) s of 5.2 and 2.9 nmol/L, respectively [1].PARP is short of poly ADP ribose polymerase and is reported as an overexpressed enzyme in a variety of cancers. |
Veliparib dihydrochloride |
|||
A3958-200 | ApexBio | 200 mg | EUR 1002 |
Description: Veliparib dihydrochloride is a potent inhibitor of PARP-1 and PARP-2 with K (i) s of 5.2 and 2.9 nmol/L, respectively [1].PARP is short of poly ADP ribose polymerase and is reported as an overexpressed enzyme in a variety of cancers. |
Veliparib dihydrochloride |
|||
A3958-5 | ApexBio | 5 mg | EUR 150 |
Description: Veliparib dihydrochloride is a potent inhibitor of PARP-1 and PARP-2 with K (i) s of 5.2 and 2.9 nmol/L, respectively [1].PARP is short of poly ADP ribose polymerase and is reported as an overexpressed enzyme in a variety of cancers. |
Veliparib dihydrochloride |
|||
A3958-5.1 | ApexBio | 10 mM (in 1mL DMSO) | EUR 139.2 |
Description: Veliparib dihydrochloride is a potent inhibitor of PARP-1 and PARP-2 with K (i) s of 5.2 and 2.9 nmol/L, respectively [1].PARP is short of poly ADP ribose polymerase and is reported as an overexpressed enzyme in a variety of cancers. |
Veliparib dihydrochloride |
|||
A3958-50 | ApexBio | 50 mg | EUR 421.2 |
Description: Veliparib dihydrochloride is a potent inhibitor of PARP-1 and PARP-2 with K (i) s of 5.2 and 2.9 nmol/L, respectively [1].PARP is short of poly ADP ribose polymerase and is reported as an overexpressed enzyme in a variety of cancers. |
Ethambutol dihydrochloride |
|||
E005-100G | TOKU-E | 100 g | EUR 508.8 |
Ethambutol dihydrochloride |
|||
E005-25G | TOKU-E | 25 g | EUR 171.6 |
Antipain, dihydrochloride |
|||
ADJ692 | Bio Basic | 5mg | EUR 110.53 |
Naftopidil Dihydrochloride |
|||
E1KS1387 | EnoGene | 25mg | EUR 296.4 |
Norquetiapine dihydrochloride |
|||
2362-250 | Biovision | EUR 496.8 |
Norquetiapine dihydrochloride |
|||
2362-50 | Biovision | EUR 170.4 |
1400W dihydrochloride |
|||
2055-25 | Biovision | EUR 405.6 |
1400W dihydrochloride |
|||
2055-5 | Biovision | EUR 151.2 |
GGACK Dihydrochloride |
|||
1847-5 | Biovision | 5 mg | EUR 382.8 |
Description: A potent and irreversible inhibitor of Urokinase (uPA (IC??<1 µM), Factor VIIa, Factor IXa, Factor Xa, and trypsin. |
PPACK Dihydrochloride |
|||
1848-5 | Biovision | EUR 301.2 |
Puromycin Dihydrochloride |
|||
1860-100 | Biovision | EUR 326.4 |
Puromycin Dihydrochloride |
|||
1860-1000 | Biovision | EUR 1554 |
Puromycin Dihydrochloride |
|||
1860-25 | Biovision | EUR 151.2 |
Puromycin Dihydrochloride |
|||
1860-250 | Biovision | EUR 548.4 |
Puromycin Dihydrochloride |
|||
1860-500 | Biovision | EUR 966 |
Emetine dihydrochloride |
|||
1970-250 | Biovision | EUR 430.8 |
Emetine dihydrochloride |
|||
1970-50 | Biovision | EUR 164.4 |
Berbamine dihydrochloride |
|||
2520-100 | Biovision | EUR 157.2 |
Berbamine dihydrochloride |
|||
2520-500 | Biovision | EUR 444 |
Vatalanib Dihydrochloride |
|||
2025-25 | Biovision | EUR 366 |
Vatalanib Dihydrochloride |
|||
2025-5 | Biovision | EUR 151.2 |
Antipain dihydrochloride |
|||
2834-25 | Biovision | EUR 392.4 |
Antipain dihydrochloride |
|||
2834-5 | Biovision | EUR 144 |
Dorsmorphin dihydrochloride |
|||
2835-25 | Biovision | EUR 705.6 |
Dorsmorphin dihydrochloride |
|||
2835-5 | Biovision | EUR 222 |
AT7867 dihydrochloride |
|||
A3199-10 | ApexBio | 10 mg | EUR 408 |
Description: IC50: AKT1 32 nM, AKT2 17 nM, AKT3 47 nM, PKA 20 nMThe serine/threonine kinase AKT plays a pivotal role in signal transduction events involved in malignant transformation and chemoresistance and is an attractive target for the development of cancer therapeutics. |